https://allsci.com/news/venture-financing/biologics-manufacturing-multiply-labs-secures-usd/ AllScien 2026-10-07T13:00:00.466906Z Multiply Labs raises USD 75m to scale robotic biologics manufacturing https://allsci.com/news/biotech/telomir-pharmaceuticals-secures-usd-56m-pipe-to/ AllScien 2026-10-07T12:53:14.985759Z Telomir raises USD 5.6m to advance Telomir-Zn into Phase I/II TNBC trial https://allsci.com/news/biotech/kymathera-series-b-secures-usd-80m-to-advance/ AllScien 2026-10-07T12:41:55.122834Z Kymathera secures USD 80m Series B to advance pan-mutant PI3K inhibitor K-1728 https://allsci.com/news/clinical-trials/mcrpc-trial-kairos-pharmas-env-105-plus/ AllScien 2026-10-07T10:25:45.692505Z Kairos reports 17.7-month PFS with carotuximab combination in Phase II prostate cancer trial https://allsci.com/news/clinical-trials/cabenuva-hiv-treatment-beats-daily-oral-therapy/ AllScien 2026-10-07T10:06:06.508381Z Cabenuva shows potential to move beyond suppressed HIV patients after Phase IIIb win https://allsci.com/news/biotech/caribou-biosciences-halts-both-car-t-programs-and/ AllScien 2026-10-07T09:48:33.930642Z Caribou Bio halts both CAR-T programs and launches sale process amid funding challenges https://allsci.com/news/biotech/ovarian-cancer-generate-biomedicines-doses-first/ AllScien 2026-10-07T09:29:27.149411Z Generate Biomedicines doses first patient in AI-designed 'armored' CAR T trial for ovarian cancer https://allsci.com/news/biotech/type-1-diabetes-zag-bio-advances-zag-101-into/ AllScien 2026-10-07T07:38:00.342684Z Zag Bio advances antigen-specific immune tolerance antibody into Phase Ib/IIa T1D trial https://allsci.com/news/biotech/fshd-treatment-epi-321-raises-lean-muscle-volume/ AllScien 2026-10-07T07:03:49.891855Z EPI-321 shows early muscle volume, strength gains in Phase I/II FSHD trial https://allsci.com/news/clinical-trials/wilson-disease-prime-medicine-doses-first-patient/ AllScien 2026-10-06T17:46:59.048799Z Prime Medicine doses first patient in prime-editing trial for H1069Q Wilson disease https://allsci.com/news/business/vaxcyte-offering-launches-usd-1b-equity-and-debt/ AllScien 2026-10-06T17:41:35.723965Z Vaxcyte launches USD 1b equity and debt raise to advance VAX-31 pneumococcal vaccine https://allsci.com/news/ipo-public-listing/retension-ipo-pharmaceuticals-files-amended-s-1/ AllScien 2026-10-06T17:39:32.938337Z Retension targets up to USD 43 million IPO to fund hypertension drug https://allsci.com/news/biotech/infigratinib-achondroplasia-fda-grants-priority/ AllScien 2026-10-06T17:38:07.627315Z BridgeBio's oral infigratinib gets US FDA Priority Review in achondroplasia https://allsci.com/news/biotech/beam-therapeutics-lawsuit-united-states-district/ AllScien 2026-10-06T17:15:55.515265Z Beam sues YolTech, former employee over alleged theft of AATD base-editing trade secrets https://allsci.com/news/clinical-trials/furvent-trial-failure-stalls-firmonertinibs/ AllScien 2026-10-06T17:04:00.692670Z ArriVent's firmonertinib falls short in global Phase III EGFR exon 20 trial https://allsci.com/news/public-offerings/spyre-therapeutics-prices-usd-350m-offering-to/ AllScien 2026-10-06T13:34:53.731179Z Spyre raises USD 350m to advance immunology pipeline following Phase II readouts https://allsci.com/news/biotech/lycia-therapeutics-ipo-files-for-with-lytac/ AllScien 2026-10-06T13:26:18.732972Z Lycia Therapeutics files for IPO with LYTAC platform and Phase I food allergy data https://allsci.com/news/biotech/chronic-sciatica-consano-bio-secures-usd-15m-to/ AllScien 2026-10-06T12:07:26.330544Z Consano Bio raises over USD 15m to advance platelet-derived sciatica therapy https://allsci.com/news/clinical-trials/prv111-patch-clears-lesions-in-21-of-22-patients/ AllScien 2026-10-06T12:06:44.352083Z Privo’s cisplatin patch shows potential to spare oral cancer surgery https://allsci.com/news/clinical-trials/breast-cancer-trial-mrd-guided-strategy-in-early/ AllScien 2026-10-06T11:58:53.546761Z AFT, Natera launch Phase III to test MRD-guided deferral of CDK4/6 therapy in early breast cancer https://allsci.com/news/clinical-trials/odm-216-trial-orion-pharma-enters-clinical-stage/ AllScien 2026-10-06T11:38:52.362536Z Orion takes first biologic into clinical testing with PVRIG/PD-L1 bispecific https://allsci.com/news/clinical-trials/asthma-study-vial-doses-first-patient-in-phase-ib/ AllScien 2026-10-06T11:21:35.778299Z Vial starts Phase Ib asthma trial of IL-13 x TSLP bispecific targeting twice-yearly dosing https://allsci.com/news/biotech/eq504-trial-equillium-wins-australian-clearance/ AllScien 2026-10-06T11:10:05.727015Z Equillium cleared to start Phase I trial of oral AhR modulator EQ504 https://allsci.com/news/biotech/newly-diagnosed-dlbcl-epcoritamab-plus-r-chop/ AllScien 2026-10-06T09:50:28.659246Z Genmab, AbbVie report 51% reduction in progression or death with frontline epcoritamab https://allsci.com/news/ipo-public-listing/trex-bio-ipo-targets-usd-125m-to-advance-treg/ AllScien 2026-10-06T09:19:38.446944Z TRexBio targets up to USD 133m in Nasdaq IPO https://allsci.com/news/licensing-and-partnerships/gate-bioscience-expands-lilly-deal-to-unlock/ AllScien 2026-10-06T09:14:26.244782Z Lilly expands Gate Bioscience partnership with potential USD 870m deal https://allsci.com/news/biotech/rougetx-funding-raises-usd-58m-series-a-to-push/ AllScien 2026-10-06T08:44:13.871554Z Leiden Uni spinout RougeTx launches with USD 58m Series A for HHT program https://allsci.com/news/biotech/hdac-drug-discovery-italfarmaco-and-verisim-life/ AllScien 2026-10-05T16:29:46.599360Z Italfarmaco and VeriSIM Life combine AI and HDAC expertise in USD 100m+ drug discovery deal https://allsci.com/news/m-a/shionogi-intrabio-acquisition-acquires-for-usd-2b/ AllScien 2026-10-05T16:28:16.302376Z Shionogi pays USD 2bn for IntraBio and two-indication rare disease drug Aqneursa https://allsci.com/news/clinical-trials/vax-31-results-meets-all-primary-endpoints-in/ AllScien 2026-10-05T16:16:06.221198Z Vaxcyte’s VAX-31 clears pivotal Phase III against Prevnar 20 and Capvaxive https://allsci.com/news/biotech/sernova-financing-and-seraxis-close-usd-112m-to/ AllScien 2026-10-05T16:15:22.377232Z Sernova and Seraxis close USD 11.2m financing to advance merger and T1D cell therapy trial https://allsci.com/news/biotech/2026-nobel-prize-karolinska-institutet-awards-in/ AllScien 2026-10-05T13:58:27.943230Z 2026 Nobel medicine prize honors Deisseroth, Hegemann and Nagel for optogenetics https://allsci.com/news/biotech/parkinsons-gcase-therapy-alector-secures-usd-100m/ AllScien 2026-10-05T13:52:06.690798Z Alector secures USD 100m upfront from Genentech for brain-penetrant GCase therapy in Parkinson's disease